市場調查報告書
商品編碼
762940

A型肉毒桿菌製劑的中國市場分析、預測

Investigation Report on China's Botulinum Toxin Type A Market, 2018-2022

出版日期: | 出版商: China Research and Intelligence | 英文 30 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供中國的A型肉毒桿菌製劑市場相關調查分析,情形,市場規模,主要製造商,市場競爭,零售價格,市場預測相關的系統性資訊。

第1章 A型肉毒桿菌製劑的相關概念

  • A型肉毒桿菌製劑的適應
  • 中國的A型肉毒桿菌製劑發展歷史
  • 中國的A型肉毒桿菌製劑的政府核准

第2章 中國的A型肉毒桿菌製劑的銷售額

  • 銷售額
    • 總銷售額
    • 銷售額:各地區
  • 銷售量
    • 總銷售量
    • 銷售量:各地區
  • 銷售情況:各劑型

第3章 中國的A型肉毒桿菌製劑主要製造商分析

  • 主要廠商的市場佔有率分析
  • Allergan
    • 企業簡介
    • 中國的銷售額
  • Lanzhou Institute of Biological Products Co., Ltd.
    • 企業簡介
    • 中國的銷售額
  • 中國違法銷售的A型肉毒桿菌製劑分析

第4章 中國的A型肉毒桿菌製劑的價格

  • Allergan (Botox)
  • Lanzhou Institute of Biological Products Co., Ltd. (Hengli)

第5章 中國的A型肉毒桿菌製劑市場預測

  • 市場發展的影響因素分析
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 1901368

As the most toxic one of the eight antigenic types of botulinum, Botulinum Toxin Type A can irreversibly unite with presynaptic membrane within one hour. The targeted striated muscle will be relaxed usually 48 to 72 hours after the injection of Botulinum Toxin Type A. And the effect is maximally visible seven to 14 days following injection. Such muscle relaxation usually lasts for three to six months but varies greatly among different people. For some people, it can last up to 18 months.

On Apr. 15, 2002, Botulinum Toxin Type A was approved by the FDA as a medical cosmetic that is injected to temporarily improve the appearance of moderate to severe glabellar lines. Later, some generic drugs appeared on the market. In addition to the imported Botulinum Toxin Type A (trade name: Botox) produced by Allergan, the Botulinum Toxin Type A products in China also include Botulinum Toxin Type A (trade name: Hengli) developed by Lanzhou Institute of Biological Products Co., Ltd.

In China, the medical use of Botulinum Toxin Type A is to treat adult blepharospasm and prosopospasm and some strabismuses, especially acute paralytic strabismus, concomitant strabismus, strabismus caused by endocrine diseases, and the strabismus that cannot be corrected surgically for those aged 12 and above. The incidence of facial neuropathy is increasing in China. Many people are attacked by prosopospasm when they are over-stressed or fatigued. Seeing global annual incidence of about 0.003%, facial neuropathy is more common in women than in men, and more common in middle-aged and elderly people than in people from other age groups.

However, more users of Botulinum Toxin Type A are women who pursue a thin face or less wrinkles. With more than 10 million cosmetic surgeries every year, the market size of medical beauty in China has exceeded USD 10 billion and is still growing. As the demand for Botulinum Toxin Type A is expanding, some medical institutions and beauty salons have begun to inject Botulinum Toxin Type A smuggled from South Korea, France, Germany, etc. for their customers. Although the Chinese government only approved the sale of Botox and Hengli, smuggled Botulinum Toxin Type A products are easily available in China.

It is expected that, with the development of China's economy, the rise of income, and the change of consumption habit, Chinese people will spend more in medical beauty, and the market size of Botulinum Toxin Type A will continue to grow in China in the next few years.

Topics Covered:

  • Status of China's medical beauty market
  • Sales of Botulinum Toxin Type A in China
  • Competition on China's Botulinum Toxin Type A market
  • Major factors influencing the development of China's Botulinum Toxin Type A market
  • Prospect of China's Botulinum Toxin Type A market from 2018 to 2022

Table of Contents

1 Relevant Concepts of Botulinum Toxin Type A

  • 1.1 Indications for Botulinum Toxin Type A
  • 1.2 Development of Botulinum Toxin Type A in China
  • 1.3 Governmental Approval of Botulinum Toxin Type A in China

2 Sales of Botulinum Toxin Type A in China, 2013-2017

  • 2.1 Sales Value of Botulinum Toxin Type A in China
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Botulinum Toxin Type A in China
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Botulinum Toxin Type A by Dosage Form in China, 2013-2017

3 Analysis on Major Manufacturers of Botulinum Toxin Type A in China, 2013-2017

  • 3.1 Analysis on Market Share of Major Manufacturers of Botulinum Toxin Type A
    • 3.1.1 Market Share by Sales Value
    • 3.1.2 Market Share by Sales Volume
  • 3.2 Allergan
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Allergan's Botulinum Toxin Type A in China
  • 3.3 Lanzhou Institute of Biological Products Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A in China
  • 3.4 Analysis on Botulinum Toxin Type A Illegally Sold in China

4 Prices of Botulinum Toxin Type A in China, 2017-2018

  • 4.1 Allergan (Botox)
  • 4.2 Lanzhou Institute of Biological Products Co., Ltd. (Hengli)

5 Prospect of China's Botulinum Toxin Type A Market, 2018-2022

  • 5.1 Major Factors Influencing Development of China's Botulinum Toxin Type A Market
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

Selected Charts

  • Chart Governmental Approval of Botulinum Toxin Type A in China
  • Chart Sales of Botulinum Toxin Type A in China, 2013-2017
  • Chart Sales Value of Botulinum Toxin Type A in Parts of China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A in China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A in Parts of China, 2013-2017
  • Chart Sales Value of Botulinum Toxin Type A Injections in China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A Injections in China, 2013-2017
  • Chart Market Share of Top 5 Manufacturers of Botulinum Toxin Type A by Sales Value in China, 2013-2017
  • Chart Market Share of Top 5 Manufacturers of Botulinum Toxin Type A by Sales Volume in China, 2013-2017
  • Chart Sales Value of Allergan's Botulinum Toxin Type A, 2013-2017
  • Chart Sales Volume of Allergan's Botulinum Toxin Type A, 2013-2017
  • Chart Sales Value of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A, 2013-2017
  • Chart Sales Volume of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A, 2013-2017
  • Chart Prices of Allergan's Botulinum Toxin Type A (Botox) in Parts of China, 2017-2018
  • Chart Prices of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A (Hengli) in Parts of China, 2017-2018
  • Chart Forecast on Sales Value of Botulinum Toxin Type A in China, 2018-2022